MVP RCT: Mind and Voice Project Randomized Control Trial

Sponsor
University of Michigan (Other)
Overall Status
Completed
CT.gov ID
NCT04018807
Collaborator
(none)
26
1
2
12.3
2.1

Study Details

Study Description

Brief Summary

The study seeks to learn more about the health behaviors of young adults. Health behaviors include relationships, physical and mental health, alcohol use, and conflicts with others. The purpose of this study is to improve prevention and intervention programs for young adults.

Condition or Disease Intervention/Treatment Phase
  • Other: Resource pamphlet
  • Behavioral: Remote Therapy
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
26 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
MVP RCT: Mind and Voice Project Randomized Control Trial
Actual Study Start Date :
Jul 22, 2019
Actual Primary Completion Date :
Jul 31, 2020
Actual Study Completion Date :
Jul 31, 2020

Arms and Interventions

Arm Intervention/Treatment
Other: Resource Pamphlet

Participants will receive a pamphlet detailing mental health and social service providers at the local, state, and national level.

Other: Resource pamphlet
The pamphlet will list violence prevention, mental health, and substance abuse services.

Experimental: Remote Therapy

Participants will receive eight 30-minute remote therapy sessions over the course of twelve weeks.

Behavioral: Remote Therapy
Remote therapy sessions will include mindfulness exercises and motivational interviewing techniques.

Outcome Measures

Primary Outcome Measures

  1. Feasibility, as Measured by Number of Sessions Completed [12 weeks]

    At least 80% of session content completed.

  2. Acceptability, as Measured by Client Satisfaction [12 weeks]

    Client satisfaction is measured by the Client Satisfaction Questionnaire Exit-8, an 8 question survey where a high score indicates client satisfaction.

  3. Usability, as Measured by a Modified Systems Usability Scale [12 weeks]

    System usability is measured by an adapted version of the Systems Usability Scale for the platform used.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 25 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Prior Alcohol Use

  • Interpersonal Violence

Exclusion Criteria:
  • Person does not understand/speak English

  • Prisoner or person being taken into custody/under house arrest

  • Person or parent/guardian unable to give consent due to insufficient cognitive orientation due to unknown reasons

  • Person unable to give consent due to insufficient cognitive orientation due to drug or alcohol use/ accidental overdose; given pain medications (fails MMSE)

  • Person diagnosed with schizophrenia

  • Person is actively suicidal or being treated for self-harm (includes overdose with the intent to harm self - not accidental)

  • Person being treated for child abuse situation

  • Deaf or visually impaired/illiterate/can't speak

  • Screened within last month or already in study

  • Combative

  • Patient died

  • Too sick in emergency department to approach (e.g. - never stabilizes, in trauma bay, intubated, on ventilator, or a Level 1 trauma)

  • Person has already refused 2 times

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hurley Medical Center Flint Michigan United States 48503

Sponsors and Collaborators

  • University of Michigan

Investigators

  • Principal Investigator: Quyen Ngo, PhD, University of Michigan

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Quyen Ngo, Research Assistant Professor, University of Michigan
ClinicalTrials.gov Identifier:
NCT04018807
Other Study ID Numbers:
  • HUM00155614
First Posted:
Jul 15, 2019
Last Update Posted:
Aug 7, 2020
Last Verified:
Aug 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 7, 2020